Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.41 USD | +3.97% |
|
+10.68% | -62.08% |
Jun. 04 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
May. 31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.79B | - | - | - | - | - | |
126B | ||||||
118B | ||||||
27.87B | - | |||||
20.95B | - | |||||
16.92B |
- Stock Market
- Equities
- INBX Stock
- Charts Inhibrx, Inc.
- Sector Chart